ReSTOR Natural +3.0D Study In Japan
Study Details
Study Description
Brief Summary
The objective of this study is to evaluate safety and effectiveness of ACRYSOF Multifocal Single-piece Intraocular Lens (IOL) Model SN6AD1 when implanted to replace the natural lens following cataract removal.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: SN6AD1 AcrySof ReSTOR Model SN6AD1 Intraocular Lens |
Device: ACRYSOF Multifocal Single-piece Intraocular Lens (IOL) Model SN6AD1
Implantation with the AcrySof ReSTOR Intraocular Lens (IOL) Model SN6AD1 following cataract removal.
|
Outcome Measures
Primary Outcome Measures
- Uncorrected Intermediate Visual Acuity [1 year after surgery]
Binocular Uncorrected Intermediate Visual Acuity, measured at 1 meter and 50 centimeters measured in decimal visual acuity. Decimal visual acuity is the normal method to measure visual acuity in Japan. A higher decimal visual acuity value indicates better visual acuity. 0.5 in decimal visual acuity means 20/40 in Snellen fraction.
- Uncorrected Distance Visual Acuity [1 year after surgery]
Binocular Uncorrected Dinstance Visual Acuity measured in decimal visual acuity. Decimal visual acuity is the normal method to measure visual acuity in Japan. A higher decimal visual acuity value indicates better visual acuity. 0.5 in decimal visual acuity means 20/40 in Snellen fraction.
- Uncorrected Near Visual Acuity [1 year after surgery]
Binocular Near Visual Acuity measured in decimal visual acuity. Decimal visual acuity is the normal method to measure visual acuity in Japan. A higher decimal visual acuity value indicates better visual acuity. 0.5 in decimal visual acuity means 20/40 in Snellen fraction.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Planned bilateral cataract removal by phacoemulsification
-
Potential postoperative best corrected visual acuity of 0.5 or over
-
1.5 Diopter (D) or less of astigmatism preoperatively, measured by keratometry
Exclusion Criteria:
-
Poorly controlled glaucoma
-
Progressive diabetic retinopathy
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Hayashi Eye Hospital | Fukuoka | Japan | 812-0011 |
Sponsors and Collaborators
- Alcon Research
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- C-07-44
Study Results
Participant Flow
Recruitment Details | Only adult subjects of either gender in need of cataract extraction in both eyes were considered for enrollment. 64 subjects were implanted bilaterally with the ACRYSOF® ReSTOR® Aspheric +3.0 D (Diopter) Add Power Intraocular Lens (IOL) Model SN6AD1 |
---|---|
Pre-assignment Detail | Subjects were examined to ensure inclusion/exclusion criteria. Only subjects who signed an informed consent and qualified to be in the study were enrolled. Subject numbers were assigned after obtaining consent meeting inclusion/exclusion criteria. Subjects were considered enrolled once implanted in the first operative eye. |
Arm/Group Title | SN6AD1 |
---|---|
Arm/Group Description | ACRYSOF® ReSTOR® Aspheric +3.0 D (Diopter) Add Power Intraocular Lens (IOL) Model SN6AD1 |
Period Title: Overall Study | |
STARTED | 64 |
COMPLETED | 63 |
NOT COMPLETED | 1 |
Baseline Characteristics
Arm/Group Title | SN6AD1 |
---|---|
Arm/Group Description | ACRYSOF® ReSTOR® Aspheric +3.0 D (Diopter) Add Power Intraocular Lens (IOL) Model SN6AD1 |
Overall Participants | 64 |
Age, Customized (Number) [Number] | |
<60 years of age |
6
9.4%
|
60 - 69 years of age |
23
35.9%
|
70 - 79 years of age |
33
51.6%
|
>80 years of age |
2
3.1%
|
Sex: Female, Male (Count of Participants) | |
Female |
60
93.8%
|
Male |
4
6.3%
|
Outcome Measures
Title | Uncorrected Intermediate Visual Acuity |
---|---|
Description | Binocular Uncorrected Intermediate Visual Acuity, measured at 1 meter and 50 centimeters measured in decimal visual acuity. Decimal visual acuity is the normal method to measure visual acuity in Japan. A higher decimal visual acuity value indicates better visual acuity. 0.5 in decimal visual acuity means 20/40 in Snellen fraction. |
Time Frame | 1 year after surgery |
Outcome Measure Data
Analysis Population Description |
---|
One patient dropped out after the visit 6 months following surgery but before the 1 year visit. |
Arm/Group Title | SN6AD1 |
---|---|
Arm/Group Description | ACRYSOF® ReSTOR® Aspheric +3.0 D (Diopter) Add Power Intraocular Lens (IOL) Model SN6AD1 |
Measure Participants | 63 |
1 meter |
0.771
|
50 centimeters |
0.861
|
Title | Uncorrected Distance Visual Acuity |
---|---|
Description | Binocular Uncorrected Dinstance Visual Acuity measured in decimal visual acuity. Decimal visual acuity is the normal method to measure visual acuity in Japan. A higher decimal visual acuity value indicates better visual acuity. 0.5 in decimal visual acuity means 20/40 in Snellen fraction. |
Time Frame | 1 year after surgery |
Outcome Measure Data
Analysis Population Description |
---|
One patient dropped out after the visit 6 months following surgery but before the 1 year visit. |
Arm/Group Title | SN6AD1 |
---|---|
Arm/Group Description | ACRYSOF® ReSTOR® Aspheric +3.0 D (Diopter) Add Power Intraocular Lens (IOL) Model SN6AD1 |
Measure Participants | 63 |
Mean (Full Range) [Decimal Visual Acuity] |
1.122
|
Title | Uncorrected Near Visual Acuity |
---|---|
Description | Binocular Near Visual Acuity measured in decimal visual acuity. Decimal visual acuity is the normal method to measure visual acuity in Japan. A higher decimal visual acuity value indicates better visual acuity. 0.5 in decimal visual acuity means 20/40 in Snellen fraction. |
Time Frame | 1 year after surgery |
Outcome Measure Data
Analysis Population Description |
---|
One patient dropped out after the visit 6 months following surgery but before the 1 year visit. |
Arm/Group Title | SN6AD1 |
---|---|
Arm/Group Description | ACRYSOF® ReSTOR® Aspheric +3.0 D (Diopter) Add Power Intraocular Lens (IOL) Model SN6AD1 |
Measure Participants | 63 |
Mean (Full Range) [Decimal Visual Acuity] |
1.082
|
Adverse Events
Time Frame | From time of surgery to 1 year following surgery. | |
---|---|---|
Adverse Event Reporting Description | ||
Arm/Group Title | SN6AD1 | |
Arm/Group Description | ACRYSOF® ReSTOR® Aspheric +3.0 D (Diopter) Add Power Intraocular Lens (IOL) Model SN6AD1 | |
All Cause Mortality |
||
SN6AD1 | ||
Affected / at Risk (%) | # Events | |
Total | / (NaN) | |
Serious Adverse Events |
||
SN6AD1 | ||
Affected / at Risk (%) | # Events | |
Total | 1/64 (1.6%) | |
Nervous system disorders | ||
Stroke | 1/64 (1.6%) | 1 |
Other (Not Including Serious) Adverse Events |
||
SN6AD1 | ||
Affected / at Risk (%) | # Events | |
Total | 0/64 (0%) |
Limitations/Caveats
More Information
Certain Agreements
Principal Investigators are NOT employed by the organization sponsoring the study.
The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
Results Point of Contact
Name/Title | Director of Alcon Clinical |
---|---|
Organization | Alcon Research, Ltd. |
Phone | 888.451.3937; 817.568.6725 |
medinfo@alconlabs.com |
- C-07-44